Chapter 10- Randomized trials Flashcards
Experimental study
A type of study where an investigator manipulates a treatment/factor of interest
(exposure, risk factor, etc.) and measures health outcomes
Randomized trials
Start with a defined population. Participants are randomly assigned to a treatment group. Compare risk of disease outcome among people with and without treatment to determine whether receiving treatment is related to the outcome
Limitations/considerations of randomized trials (3)
- Ethics in clinical research
- Selection of subjects
- Treatment concealment + control regime
Belmont report
Contained 3 key principles:
Respect for Persons
Beneficence
Justice
Respect for persons
The idea that individuals should be treated as autonomous
Beneficence
Effort should be made to reduce harm and maximize benefits for participants. This is a risk-benefit assessment where expected benefits should far outweigh the potential harms.
Justice
Benefits of research should be evenly distributed among all involved species. There should be clear principles for inclusion/exclusion
of populations in research- eligibility criteria in a study is an example of this
3 elements of informed consent
- Information
- Comprehension
- Voluntariness
Selection of subjects in RCTs
The criteria for determining who will and will not be included in the study should be described in writing before the study begins. There should be no element of subjective decision making on the part of the investigator.
Masking (blinding)
Subjects should not know which group they are assigned to, especially when the outcome is a subjective measure. This can be accomplished using a placebo. The observers or data collectors should also be blinded in regard to which group the patient is in
Considerations for selection of control regime
- Ethical: What is standard of care?
- Practical: What control can help to maintain blinding?
How does randomization reduce bias?
Assignment of treatment group due to chance alone. It aims to reduce potential bias in treatment-outcome relationships that can arise consciously or unconsciously from investigators or participants
Planned crossover
Subjects are randomized to new treatment or current treatment. They are observed for a certain period of time. After any changes are measured, patients are switched to the other therapy and observed again. Each patient serves as their own control
Carryover
A potential concern of a planned crossover design- once treatment is switched, there should not be any residual effects from the initial treatment impacting the outcome of the second treatment. The order in which the treatments are given may cause psychological effects that can impact treatment
Unplanned crossover
Subjects randomized to one treatment (like surgery) might eventually decide not to have the surgery. Some controls may have their health decline and then need surgery. Therefore, patients may need to be switched between groups. This may make it challenging to analyze the data